MONTREAL, CANADA–(Marketwired – July 14, 2015) – Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that COFEPRIS, Mexico’s health agency, has approved the 2mg/vial presentation of tesamorelin for the treatment […]
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Marketwiredhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngMarketwired2015-07-14 04:30:002015-07-14 21:14:03EGRIFTA (Tesamorelin for Injection) Approved in Mexico